News
2h
Newspoint on MSNIf you want to keep your liver safe, then keep an eye on this disease, as it makes you hollow from the inside.Diabetes is not just limited to increased sugar; it also affects the health of the liver. The liver works to store glucose in ...
In a majority of cases, liver cancer does not doesn't have to happen if people avoid risk factors, a new global study ...
Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...
Serious liver disease is becoming more common among Americans who drink heavily, according to a new study from Keck Medicine ...
41m
GB News on MSNWhat time do you go to bed? Your sleep schedule may double your risk of liver cirrhosisErratic sleeping schedules have been found to significantly increase the likelihood of developing liver cirrhosis, with those ...
The Independent on MSN1d
The simple changes that could prevent three in five liver cancer casesSimple lifestyle changes could drastically cut cases of liver cancer, according to academics. The Lancet Commission on liver ...
1d
MedPage Today on MSNAt Least 60% of Liver Cancers Tied to Preventable Risk FactorsSixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...
2h
VnExpress International on MSNLiver cancer to double worldwide, most of it preventable: studyThe number of people with liver cancer will nearly double worldwide by 2050 unless more is done to address preventable causes ...
U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...
The prevalence of significant liver disease associated with heavy alcohol use has increased over the past two decades despite ...
Alcohol-related liver disease has more than doubled in the U.S. over the last 20 years.
Madrigal Pharmaceuticals said on Wednesday it has entered into a licensing agreement worth up to $2 billion with China's CSPC Pharmaceutical Group to develop an oral GLP-1 drug for a serious form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results